Pregnancy SmartSiteTM

Skip Navigation Schedule An Appointment

Normal Pregnancy

Staying Healthy

Alcohol and pregnancy Managing your weight gain in pregnancy Steps to take before you get pregnant When you need to gain more weight during pregnancy

What to expect during pregnancy

Aches and pains during pregnancy Choosing the right practitioner Common symptoms during pregnancy Hyperemesis Gravidarum Morning sickness Pregnancy and travel Pregnancy and work Problems sleeping during pregnancy Skin and hair changes during pregnancy Teenage pregnancy

Preparing to go home with your baby

Cribs and crib safety Eat right during pregnancy Preparing your other children

Visits and Tests

Amniocentesis Chorionic villus sampling Genetic counseling before pregnancy Glucose tolerance test-pregnancy Monitoring your baby before labor Nuchal translucency Prenatal care in your first trimester Prenatal care in your second trimester Prenatal care in your third trimester

Chagas disease

Definition

Chagas disease is an illness caused by tiny parasites and spread by insects. The disease is common in South and Central America.

Causes

Chagas disease is caused by the parasite Trypanosoma cruzi. It is spread by the bite of reduviid bugs, or kissing bugs, and is one of the major health problems in South America. Due to travel and immigration, the disease also affects people in the United States.

Risk factors for Chagas disease include:

Symptoms

Chagas disease has two phases: acute and chronic. The acute phase may have no symptoms or very mild symptoms, including:

After the acute phase, the disease goes into remission. There may be no other symptoms for many years. When symptoms finally develop, they may include:

Exams and Tests

A physical exam can confirm the symptoms. Signs of Chagas disease may include:

Tests include:

Treatment

The acute phase of reactivated Chagas disease should be treated. Infants born with the infection should also be treated.

Treating the chronic phase is recommended for children and most adults. Adults with chronic phase Chagas disease should talk to their health care provider to decide whether treatment is needed.

Two medicines are used to treat this infection: benznidazole and nifurtimox.

Both medicines often have side effects. The side effects may be worse in older people. They may include:

Outlook (Prognosis)

About one third of infected people who are not treated will develop chronic or symptomatic Chagas disease. It may take more than 20 years from the time of the original infection to develop heart or digestive problems.

Abnormal heart rhythms may cause sudden death. Once heart failure develops, death usually occurs within several years.

Possible Complications

Chagas disease can cause these complications:

When to Contact a Medical Professional

Contact your provider for an appointment if you think you may have Chagas disease.

Prevention

Insect control with insecticides and houses that are less likely to have high insect populations will help control the spread of the disease.

Blood banks in Central and South America screen donors for exposure to the parasite. The blood is discarded if the donor has the parasite. Most blood banks in the United States began screening for Chagas disease in 2007.

References

Kirchoff LV. Chagas disease. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 318.

Kirchhoff LV. Trypanosoma species (American trypanosomiasis, Chagas' disease): biology of trypanosomes. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 276.

Salvana EMT, Salata RA. American Trypanosomiasis (Chagas Disease; Trypanosoma cruzi). In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 333.

Schedule An Appointment

Contact Atlanta Obsetrics and Gynaecology at The Womens Center Millennium Hospital - 404-ATL-BABY

GO

Review Date: 11/10/2024

Reviewed By: Jatin M. Vyas, MD, PhD, Professor in Medicine, Harvard Medical School; Associate in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.